Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Cappello

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Elife|August 7, 2023
Force propagation between epithelial cells depends on active coupling and mechano-structural polarizationArtur Ruppel, Dennis Wörthmüller, Vladimir Misiak, et al.
The European Physical Journal. E, Soft Matter|June 24, 2025
Osmotic pressure induces unexpected relaxation of contractile 3D microtissueGiovanni Cappello, Fanny Wodrascka, Genesis Marquez-Vivas, et al.
Cancers|January 11, 2022
Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver MetastasesValentina Giannini, Laura Pusceddu, Arianna Defeudis, et al.
Antibiotics (Basel, Switzerland)|December 1, 2020
Antibacterial and Anti-Inflammatory Activity of an Antimicrobial Peptide Synthesized with D Amino AcidsJlenia Brunetti, Veronica Carnicelli, Alessia Ponzi, et al.
International Journal of Cancer|September 3, 2020
Radiomics predicts response of individual HER2-amplified colorectal cancer liver metastases in patients treated with HER2-targeted therapyValentina Giannini, Samanta Rosati, Arianna Defeudis, et al.
European Journal of Radiology Open|July 24, 2023
A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST)Giovanni Cappello, Valentina Giannini, Roberto Cannella, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 29, 2025
Novel Diffuse Midline Glioma-on-Chip Recapitulating Tumor Biophysical Microenvironment to Assess the Heterogeneity of Response to TherapiesLisa Terrassoux, Calypso Hazard, Agathe Laratte, et al.
Nature Medicine|August 1, 2022
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trialAndrea Sartore-Bianchi, Filippo Pietrantonio, Sara Lonardi, et al.
ESMO Open|September 29, 2020
Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trialAndrea Sartore-Bianchi, Sara Lonardi, Cosimo Martino, et al.
Scientific Reports|October 21, 2020
Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancersHarini Veeraraghavan, Claire F Friedman, Deborah F DeLair, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Elife|August 7, 2023
Force propagation between epithelial cells depends on active coupling and mechano-structural polarizationArtur Ruppel, Dennis Wörthmüller, Vladimir Misiak, et al.
The European Physical Journal. E, Soft Matter|June 24, 2025
Osmotic pressure induces unexpected relaxation of contractile 3D microtissueGiovanni Cappello, Fanny Wodrascka, Genesis Marquez-Vivas, et al.
Cancers|January 11, 2022
Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver MetastasesValentina Giannini, Laura Pusceddu, Arianna Defeudis, et al.
Antibiotics (Basel, Switzerland)|December 1, 2020
Antibacterial and Anti-Inflammatory Activity of an Antimicrobial Peptide Synthesized with D Amino AcidsJlenia Brunetti, Veronica Carnicelli, Alessia Ponzi, et al.
International Journal of Cancer|September 3, 2020
Radiomics predicts response of individual HER2-amplified colorectal cancer liver metastases in patients treated with HER2-targeted therapyValentina Giannini, Samanta Rosati, Arianna Defeudis, et al.
European Journal of Radiology Open|July 24, 2023
A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST)Giovanni Cappello, Valentina Giannini, Roberto Cannella, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 29, 2025
Novel Diffuse Midline Glioma-on-Chip Recapitulating Tumor Biophysical Microenvironment to Assess the Heterogeneity of Response to TherapiesLisa Terrassoux, Calypso Hazard, Agathe Laratte, et al.
Nature Medicine|August 1, 2022
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trialAndrea Sartore-Bianchi, Filippo Pietrantonio, Sara Lonardi, et al.
ESMO Open|September 29, 2020
Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trialAndrea Sartore-Bianchi, Sara Lonardi, Cosimo Martino, et al.
Scientific Reports|October 21, 2020
Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancersHarini Veeraraghavan, Claire F Friedman, Deborah F DeLair, et al.
Pageof 7